Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,286,857 papers from all fields of science
Search
Sign In
Create Free Account
reniale
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Cancer Vaccines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Specific immunotherapy in renal cancer: a systematic review
A. Hirbod‐Mobarakeh
,
Hesam Addin Gordan
,
+4 authors
N. Rezaei
Therapeutic Advances in Urology
2017
Corpus ID: 24757135
Background: Renal cell cancer (RCC) is the tenth most common malignancy in adults. In recent years, several approaches of active…
Expand
2014
2014
Drugs in Clinical Development for Renal Cancer Summary and Table
Pharmaceutical Medicine
2014
Corpus ID: 256367833
Review
2012
Review
2012
Treatment of Locally Advanced Renal Cell Carcinoma
T. Hüsch
,
M. Reiter
,
R. Mager
,
M. Kurosch
,
A. Haferkamp
2012
Corpus ID: 29838770
Review
2009
Review
2009
Vaccine therapy in patients with renal cell carcinoma.
H. V. Van Poppel
,
S. Joniau
,
S. V. Van Gool
European Urology
2009
Corpus ID: 1630004
2009
2009
Adjuvante autologe Tumorvakzine beim Nierenzellkarzinom
M. May
,
F. Kendel
,
+5 authors
S. Brookman‐Amissah
Der Urologe
2009
Corpus ID: 116578679
ZusammenfassungHintergrundBeim lokal begrenzten Nierenzellkarzinom (NZK) tritt nach chirurgischer Therapie in nahezu einem…
Expand
Review
2009
Review
2009
Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
P. Clark
European Urology
2009
Corpus ID: 35662722
2008
2008
Does adjuvant vitespen prevent recurrence in patients with locally advanced kidney cancer?
C. Doehn
,
D. Jocham
Nature Clinical Practice Urology
2008
Corpus ID: 29809322
Wood and colleagues present the results from a randomized phase III trial comparing adjuvant vitespen therapy with observation…
Expand
2007
2007
Gibt es eine Indikation zur neoadjuvanten oder adjuvanten Systemtherapie beim Nierenzellkarzinom?
C. Doehn
,
A. Merseburger
,
D. Jocham
,
M. Kuczyk
Der Urologe
2007
Corpus ID: 29936574
ZusammenfassungDas Nierenzellkarzinom besitzt von allen urologischen Tumoren die schlechteste Prognose. In den meisten Fällen…
Expand
2007
2007
[Is there an indication for neoadjuvant or adjuvant systemic therapy in renal cell cancer?].
C. Doehn
,
A. Merseburger
,
D. Jocham
,
M. Kuczyk
Der Urologe (Ausg. A)
2007
Corpus ID: 41155279
Looking at the most frequent urological tumors kidney cancer has the worst prognosis. Primary therapy consists of operative tumor…
Expand
2006
2006
AN ADJUVANT VACCINATION WITH RENIALE® PROLONGS SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA FOLLOWING RADICAL NEPHRECTOMY: SECONDARY ANALYSIS OF A MULTICENTRE PHASE-III TRIAL
C. Doehn
,
A. Richter
,
R. Theodor
,
W. Lehmacher
,
D. Jocham
2006
Corpus ID: 72218449
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required